Sildenafil (marketed as Viagra and Revatio) Information
To report any serious adverse events associated with the use of this drug, please contact the FDA MedWatch program using the contact information at the bottom of this page.
Related Information
- FDA Drug Saftey Communication: FDA clarifies Warning about Pediatric Use of Revatio (sildenafil) for Pulmonary Arterial Hypertension
- FDA Drug Safety Communication: FDA recommends against use of Revatio in children with pulmonary hypertension
- Comunicado de la FDA sobre la seguridad de los medicamentos La FDA recomienda que no se use Revatio en niños con hipertensión pulmonary